Clinical Trial Update: Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of the ZoMaxx Drug-Eluting Stent System in coronary arteries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• ZoMaxx Drug-Eluting Stent System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Disease, Coronary Artery Disease | Phase 2 | Status: COMPLETED